Orbimed Advisors LLC Scholar Rock Holding Corp Transaction History
Orbimed Advisors LLC
- $3.69 Billion
- Q4 2024
A detailed history of Orbimed Advisors LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Orbimed Advisors LLC holds 151,800 shares of SRRK stock, worth $5.94 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
151,800
Previous 742,300
79.55%
Holding current value
$5.94 Million
Previous $5.95 Million
10.34%
% of portfolio
0.18%
Previous 0.14%
Shares
11 transactions
Others Institutions Holding SRRK
# of Institutions
257Shares Held
88.6MCall Options Held
1.82MPut Options Held
1.17M-
Price T Rowe Associates Inc Baltimore, MD9.28MShares$363 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY9.25MShares$362 Million17.66% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$222 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA5.61MShares$220 Million74.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.74MShares$186 Million0.0% of portfolio
About Scholar Rock Holding Corp
- Ticker SRRK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,640,600
- Market Cap $2.02B
- Description
- Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...